Tulane University has announced an extra day of some programming and also a national headliner to the Immersion Days this year. This premier event of the University will be presenting its latest research findings to the biotechnology firms, some venture capitalists, a few foundations and also some potential collaborators. The Immersion days 2019 will be scheduled from April 9th to April 10th.
The event will be featuring some advances in the development of vaccines, brain research, some diagnostic technology, and biomedical engineering and etc.
“We’re thrilled to have Dr. Heaton as this year’s keynote speaker for Immersion Days 2019,” said James Zanewicz, the chief business officer. “The Bill & Melinda Gates Medical Research Institute is a perfect example of the kind of innovation and progress that is possible when academic researchers, biotechnology and pharmaceutical companies and global health organizations work together to solve global problems.”
The Gates MRI is basically a nonprofit organization of biotechnology that generally applies translational science in order to fight against diseases that impact the poor people in underdeveloped countries.
The faculty will be presenting some updates on the study in order to regenerate some bone and soft tissue, a few advances to fight cancer in medical imaging technology, some investigations related to aging and genetics, and efforts to use the nanoparticles obtained from bacteria so new vaccines can be developed and much more.
“Like last year, this will be a tasting menu of some of our most innovative science in an easily accessible format for those in the private sector to learn more about our research,” Zanewicz said. “This year we’re featuring an all new lineup of scientists and expanding to welcome faculty from the School of Science and Engineering to join those from our medical school and showcase the wide breadth of biomedical research happening in labs across Tulane.”
The Immersion Days will also be including some discussion panels regarding the venture capital investment and garnering support from a few national foundations or even collaborative partnerships.